TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) EBIT Margin (2023)

Updated

TFA Therapeutics (RAJAF) recorded EBIT Margin of -11.33% in FY2025, up 3.34 percentage points from -14.67% in FY2024.

Analysis

TFA Therapeutics (RAJAF) EBIT Margin (2023) Analysis & Trends

Starting with FY2020, TFA Therapeutics' EBIT Margin history includes 6 years.

  • Annual EBIT Margin has a five-year change of -17.81 percentage points (FY2020 to FY2025).
  • Annual EBIT Margin has ranged from -778.78% in FY2022 to 25.82% in FY2023 over the past five years.
  • Per Business Quant data, RAJAF's EBIT Margin was -14.67% in FY2024 (-40.49 pp), 25.82% in FY2023 (+804.60 pp), -778.78% in FY2022 (-765.20 pp) and -13.58% in FY2021 (-20.06 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Procter & Gamble 387.18 Bn 342.94 Bn 10.28 Bn 18.63%
2 Colgate Palmolive 77.71 Bn 72.44 Bn 3.30 Bn 18.95%
3 Estee Lauder Companies 39.01 Bn 27.08 Bn 2.74 Bn -1.08%
4 Kenvue 38.07 Bn 33.69 Bn 2.30 Bn 17.67%
5 Kimberly Clark 37.24 Bn 34.44 Bn 1.60 Bn 15.11%
6 Church & Dwight 25.71 Bn 24.24 Bn 693.90 Mn 18.07%
7 Clorox 10.75 Bn 9.02 Bn 804.00 Mn 24.33%
8 e.l.f. Beauty 6.78 Bn 5.75 Bn 398.84 Mn 21.37%
9 Reynolds Consumer Products 4.95 Bn 4.61 Bn 245.00 Mn 14.62%
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 38.18%
API Access

TFA Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=RAJAF&period=max&api_key=YOUR_API_KEY